[Myocardial structure in various forms of hypertrophy. II. Myocyte hypertrophy or hyperplasia? Results of the study]

S Grajek1, S Paradowski, M Zajac

  • 1Kliniki Kardiologii Instytutu Kardiologii AM w Poznaniu.

Kardiologia Polska
|January 1, 1990
PubMed

Insights

Cardiac muscle hypertrophy involves changes in myocyte size and number. Increased heart weight above 250g leads to myocyte hyperplasia, a result of cardiac muscle mass increase.

Area of Science:

  • Cardiovascular pathology
  • Cardiac remodeling
  • Histopathology

Background:

  • Cardiac muscle hypertrophy is a common adaptation to increased workload.
  • Understanding the cellular mechanisms of hypertrophy is crucial for diagnosing and managing heart disease.

Purpose of the Study:

  • To investigate the relationship between left ventricular (LV) weight and myocyte characteristics in hypertrophied hearts.
  • To determine the role of myocyte hyperplasia in cardiac enlargement.

Main Methods:

  • Histometric analysis of myocyte diameter, length, volume, density, and number in 103 human hearts.
  • Correlation of these parameters with LV weight.
  • Evaluation of factors influencing LV weight, including coronary artery diameter and atherosclerosis.

Main Results:

  • Histometric parameters correlated with LV weight up to 350g; heavier hearts showed similar magnitudes.
  • Myocyte number was significantly higher in hearts >250g (5.53 x 10^9) vs <250g (4.31 x 10^9).
  • LV weight was influenced by coronary artery diameters; myocyte hyperplasia was observed in hearts >250g, irrespective of etiology.

Conclusions:

  • Cardiac muscle mass increase leads to myocyte hyperplasia.
  • Hypertrophy progresses to hyperplasia beyond a certain threshold of LV weight.
  • Myocyte hyperplasia is a common finding in advanced heart failure, regardless of the underlying cause.

Related Concept Videos

Structure of Cardiac Muscles01:13

Structure of Cardiac Muscles

Cardiac muscle, or myocardium, is a specialized type of muscle found exclusively in the heart. Its unique structural and functional characteristics enable the heart to perform its vital role of pumping blood throughout the body continuously and rhythmically. The cardiac muscle cells, or cardiomyocytes, possess an endomysium and perimysium but do not have an epimysium.
Compared to skeletal muscles, cardiac muscle cells are small and mostly have a single nucleus. Additionally, they are usually...
Myocarditis I: Introduction01:21

Myocarditis I: Introduction

Myocarditis is inflammation of the myocardium, which is the muscular layer of the heart.EtiologyMyocarditis has a diverse etiology, including a wide range of infectious and non-infectious causes:Infectious CausesViral: Common viruses include Coxsackie A and B, adenovirus, parvovirus B19, enteroviruses, and influenza A.Bacterial: Examples include infections caused by Streptococcus, Staphylococcus, and Mycoplasma species.Rickettsial: Infections like Rocky Mountain spotted fever can result in...
Myocarditis II: Clinical Features and Diagnostic Tests01:27

Myocarditis II: Clinical Features and Diagnostic Tests

Myocarditis is an inflammation of the heart muscle. The symptoms vary widely, encompassing asymptomatic presentations to severe, acute manifestations.Clinical PresentationAsymptomatic cases: In some instances, myocarditis may be asymptomatic, with the infection resolving without intervention. These cases often go undetected unless discovered incidentally through diagnostic imaging or tests conducted for other reasons.General Early Symptoms: Early symptoms of myocarditis are non-specific and can...
Heart Failure II: Pathophysiology01:29

Heart Failure II: Pathophysiology

Systolic Heart Failure and Compensatory MechanismsSystolic heart failure (also termed HFrEF, Heart Failure with Reduced Ejection Fraction) is the most prevalent type of heart filure. It results in a decreased volume of blood being pumped from the ventricle. The aortic arch and carotid sinuses have baroreceptors that detect reduced blood pressure, triggering the sympathetic nervous system (SNS) to release epinephrine and norepinephrine. Initially, this response aims to boost heart rate and...
Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
Cellular Adaptation II: Hypertrophy01:26

Cellular Adaptation II: Hypertrophy

Hypertrophy is the increase in the size of individual cells, resulting in the enlargement of a tissue or organ. Unlike hyperplasia, which involves an increase in cell number, hypertrophy is characterized by an increase in cell volume. This process often occurs in response to higher functional demand or hormonal stimulation, leading to the production of more structural proteins and organelles, thereby enhancing the cells' work capacity.There are two primary types of hypertrophy: physiological...